Uncovering Institutional Buying In Roivant Sciences Ltd (NASDAQ: ROIV)
Currently, there are 806.68M common shares owned by the public and among those 376.18M shares have been available to trade. The company’s stock has a 5-day price change of -2.74% and 7.67% over the past three months. ROIV shares are trading 1.25% year to date (YTD), with the 12-month market performance down to -2.65% lower. […]
Set Your Sights On Roivant Sciences Ltd (NASDAQ: ROIV)’S Upside Potential
Roivant Sciences Ltd (ROIV) concluded trading on Thursady at a closing price of $11.36, with 5.08 million shares of worth about $57.69 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.88% during that period and on Thursady the price saw a loss of […]
Is Roivant Sciences Ltd (NASDAQ: ROIV) Back In The Buying Zone?
Currently, there are 760.14M common shares owned by the public and among those 478.44M shares have been available to trade. However, the script later moved the day high at 10.90, up 0.56%. The company’s stock has a 5-day price change of 8.48% and 27.13% over the past three months. ROIV shares are trading -3.21% year […]
Roivant Sciences Ltd (NASDAQ: ROIV) Not A Good Play Anymore?
Roivant Sciences Ltd (ROIV) concluded trading on Wednesday at a closing price of $10.39, with 4.64 million shares of worth about $48.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.78% during that period and on Wednesday February 7 the price saw a […]
Roivant Sciences Ltd (ROIV) Volatility Spurs A Quest For Clarity
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $436.66 million. In […]
Roivant Sciences Ltd (NASDAQ: ROIV) Has Another Chance To Impress You
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $436.66 million. In […]
Roivant Sciences Ltd (NASDAQ: ROIV) Hogging The Spotlight Today
Fidelity Management & Research Co recently announced the acquisition of new stake in Roivant Sciences Ltd (NASDAQ:ROIV). The institutional investor has increased its shareholding in the Healthcare company by 8.10% to 38.88 million shares with purchase of 2.91 million shares. This fresh investment now brings its stake to 4.84% valued currently at $371.72 million. In […]
Growth Story Still Intact For Roivant Sciences Ltd (ROIV)
Fidelity Management & Research Co has recently announced that it has increased stake in Roivant Sciences Ltd (NASDAQ:ROIV) by 8.10%. After grabbing 38.88 million shares, the institutional investor is now in possession of 2.91 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.84% having worth around $371.72 […]
